Gilman Sydney A. 4
4 · DiaMedica Therapeutics Inc. · Filed Jul 29, 2021
Insider Transaction Report
Form 4
Gilman Sydney A.
VP, Regulatory Affairs
Transactions
- Award
Stock Option (right to buy)
2021-07-28+25,000→ 25,000 totalExercise: $5.00Exp: 2031-07-27→ Common Shares (25,000 underlying)
Holdings
- 0
Voting Common Shares, no par value per share
Footnotes (1)
- [F1]Vests in sixteen nearly equal quarterly installments over four years.